Home/Filings/4/0001127602-24-014859
4//SEC Filing

Santos Esteban 4

Accession 0001127602-24-014859

CIK 0000318154other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 7:08 PM ET

Size

9.0 KB

Accession

0001127602-24-014859

Insider Transaction Report

Form 4
Period: 2024-05-07
Santos Esteban
EVP, Operations
Transactions
  • Award

    Nqso (Right to Buy)

    2024-05-07$300.30/sh+19,469$5,846,54138,938 total
    Exercise: $300.30From: 2026-05-07Exp: 2034-05-07Common Stock (19,469 underlying)
  • Award

    Common Stock

    2024-05-07$300.30/sh+2,997$899,99971,304 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    856.611
Footnotes (5)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.
  • [F2]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,348 RSUs which will vest on 4/30/2025; 2,437 RSUs which will vest in installments of 1,200 on 5/2/2025, and 1,237 on 5/2/2026; 3,559 RSUs which will vest in two installments of 1,174 each on 5/2/2025 and 5/2/2026, and one installment of 1,211 on 5/2/2027; and 2,997 RSUs which will vest in two installments of 989 on 5/7/2026 and on 5/7/2027, and one installment of 1,019 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F3]These shares include 425 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  • [F4]These shares are acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
  • [F5]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001677950

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 7:08 PM ET
Size
9.0 KB